Stifel Financial Corp Takes $1.26 Million Position in Smith & Nephew plc (NYSE:SNN)

Stifel Financial Corp bought a new stake in Smith & Nephew plc (NYSE:SNN - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 40,399 shares of the medical equipment provider's stock, valued at approximately $1,258,000.

Other large investors have also added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC increased its position in Smith & Nephew by 1,894.3% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,735 shares of the medical equipment provider's stock valued at $43,000 after buying an additional 1,648 shares in the last quarter. EverSource Wealth Advisors LLC boosted its stake in Smith & Nephew by 92.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,454 shares of the medical equipment provider's stock worth $61,000 after purchasing an additional 1,179 shares in the last quarter. GAMMA Investing LLC increased its stake in Smith & Nephew by 160.0% during the 3rd quarter. GAMMA Investing LLC now owns 2,257 shares of the medical equipment provider's stock valued at $70,000 after purchasing an additional 1,389 shares in the last quarter. Blue Trust Inc. lifted its stake in shares of Smith & Nephew by 460.5% during the third quarter. Blue Trust Inc. now owns 4,658 shares of the medical equipment provider's stock worth $145,000 after buying an additional 3,827 shares during the period. Finally, Coerente Capital Management acquired a new stake in shares of Smith & Nephew during the third quarter worth $202,000. 25.64% of the stock is currently owned by institutional investors.

Smith & Nephew Stock Performance

Shares of SNN stock traded down $0.12 on Monday, hitting $24.54. The company had a trading volume of 1,283,193 shares, compared to its average volume of 865,298. Smith & Nephew plc has a twelve month low of $23.65 and a twelve month high of $31.72. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63. The firm has a market cap of $10.73 billion, a P/E ratio of 12.52, a price-to-earnings-growth ratio of 1.41 and a beta of 0.84. The company has a 50-day moving average price of $26.21 and a 200-day moving average price of $27.90.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on SNN. Berenberg Bank lowered Smith & Nephew from a "buy" rating to a "hold" rating in a research note on Wednesday, November 6th. Deutsche Bank Aktiengesellschaft cut Smith & Nephew from a "buy" rating to a "hold" rating in a research note on Friday, November 1st. Finally, StockNews.com cut shares of Smith & Nephew from a "strong-buy" rating to a "buy" rating in a research note on Tuesday, November 12th.

Smith & Nephew Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.